Figure 5From: Characterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activitiesThe effects of SAK and RGD-SAK on platelet aggregation. The means ± SD came from six independent experiments. Results are expressed as a percent inhibition in relation to platelets incubated with no recombinant proteins taken as 100%. The statistical differences between the inhibitory effects of RGD-SAK and SAK for each tested concentration are significant (P < 0.01).Back to article page